The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions.If you have any queries about the SPCs on our website then please e-mail vetinfo@hpra.ie


PARVORUVAX



Ceva Santé AnimaleVPA10815/052/001

Main Information

Trade NamePARVORUVAX
Active SubstancesPorcine parvovirus inactivated k-22 strain
Erysipelothrix rhusiopathiae (lysed bacterial cells), serotype 2
Dosage FormSuspension for injection
Licence HolderCeva Santé Animale
Licence NumberVPA10815/052/001

Group Information

ATC CodeQI09AL01 porcine parvovirus + erysipelothrix
Therapeutic ClassImmunological - Inactivated Vaccine
SpeciesPigs

Status

License statusAuthorised
Licence Issued01/05/2002
Legal StatusLM: Licensed Merchant as defined in relevant national legislation

Documents

Summary of Product Characteristics *PDF Version
Package LeafletNo document available
Public Assessment ReportNo document available
VariationsNo document available

* The PDF document, together with the national-specific product information on this page, constitute the authorised SPC
« Back